|
(b)(4).Investigation: the complaint device was not returned to aid in the investigation.A document based investigation was conducted which included reviews of complaint history records, device history records, instructions for use (ifu), and quality control documents.A review of the device history record did not note any non-conformances related to the reported failure mode.A review of complaint history revealed this is the only complaint associated with lot number 8542019.There is no information leading up to the time the device was discovered severed.It is not certain how long the device has been placed when the separation occurred.There is no mention of difficulty placing the device or any force used that may have caused damage to the device.It is not known how the device was connected to pumps or iv lines that may have caused pulling or inadvertent tension on the device when patient repositioned or attempted adl¿s.There is no information about securing the device to prevent any unnecessary pulling or twisting.There is no information regarding patient behavior (e.G., cognitive level, confusion, anxiety) that may have contributed to inadvertent pulling on the device.There is no information regarding maintenance, care, use and/or flushing of the device that may have contributed to this event.It is not known what type of dressing was used with the device.A review of relevant manufacturing documents was conducted.It was concluded that the device aspect in question was visually/functionally inspected by quality control and no related gaps in production or processing controls were noted.The risk specification for this product includes the loss of use failure mode and identifies the risk controls that are in place to mitigate the risk of this type of failure.A definitive root cause for this event could not be identified, however additional measures are being initiated to investigate this issue.Similar complaints will be continued to be monitored and the appropriate personnel have been notified.This report includes information known at this time.A follow up report will be submitted should additional relevant information become available.
|
|
It was reported a turbo-ject power injectable picc line tubing separated at the valve.The line was clamped, soaked with betadine, covered with a sterile compress and wrapped.The device was removed and replaced in a second procedure three days after the separation was identified.To date, additional information regarding the patient, event and device have been requested but not yet provided.As reported, the patient did not experience any adverse effects due to this occurrence.
|